A U.S. Patent for “Data-Driven Prediction of Drug Combinations that Mitigate Adverse Drug Reactions” was awarded to IBM on November 26th, 2019. The present invention is a method for predicting beneficial drug combinations that mitigate adverse drug reactions, the method comprising: identifying a candidate set of drug combinations and target adverse drug reaction from at least one spontaneous reporting system comprising case reports of drugs and associated adverse drug reactions, each drug combination in the candidate set of drug combinations comprising a first drug associated with increasing a rate of occurrence… Learn More